On today's show: Academy Award winner Michael Douglas joins us to discuss his latest film, King of California. Then director Michael Verhoeven describes his new documentary about Germany's continuing struggle to understand Nazi atrocities. Also, a Newsweek writer explains how luxury goods became a $157 billion global industry. And on today's Please Explain, we’ll learn all about over-the-counter painkillers.
Michael Douglas has gotten rave reviews for his role in the dark comedy King of California. He plays Charlie, a man just off a two-year stint in a mental institution trying to reconnect with his long-suffering teenage daughter. His schemes to reverse the family's fortunes bring them together, for better or worse.
King of California opens on September 14 at the Lincoln Square Cinemas and the Angelika Film Center.
From 1999 to 2004, the Wehrmacht-Exhibition toured eleven German cities, reaching an audience of more than 500,000. The show shocked the nation by presenting documentary evidence that a large number of ordinary army soldiers, not just a fanatical minority in notorious SS units, were behind Nazi atrocities during World War II. Director Michael Verhoeven's new film, The Unknown Soldier, explores reactions to the controversial exhibition from historians, critics, and many Germans who attended it.
The Unknown Soldier opens on September 7 at Quad Cinema.
Weigh in: Have you seen the Wehrmacht-Exhibition?
In Deluxe, Newsweek writer Dana Thomas tells the stories behind the world's most famous luxury labels: how they came to be, why consumers love them, and where they fit in today's global economy.
Purchase Deluxe: How Luxury Lost Its Luster at amazon.com.
Weigh in: Have luxury goods lost their luster?
Americans spend more than $2 billion annually on non-prescription pain relievers. Today we'll find out what they are, how they work, how they differ from one another and from prescription drugs, what side effects they cause, and more. Rear Admiral Sandra Kweder, MD, deputy director of the Food and Drug Administration's Office of New Drugs, is here to answer your questions on aspirin, ibuprofen, acetaminophen, and all the rest.
Call us at 212-433-WNYC or post your questions and comments here.
Search current and archival WNYC broadcasts. More